Josh Wolfe is a Co-Founder and Managing Partner of Lux Capital, focusing on investments in nanotechnology, semiconductors and life sciences. Wolfe manages Lux Capital's investments in Nanosys and Cambrios, and serves on the Board of Directors of Crystal IS and Lux Research.
Before forming Lux Capital, Wolfe worked in Salomon Smith Barney's Investment Banking group, where his experience included a $4 billion hotel merger and a defense against an unsolicited LBO. Josh has also worked in capital markets while at Merrill Lynch on its Financial Futures & Options/Government Strategy desk and at Prudential Securities in its Municipal Finance department.
Josh Wolfe graduated with distinction from Cornell University with a B.S. in Economics and Finance.
Okay, so the question is, will nanotech be like biotech or pharmaceuticals, in that things are always going to be patented or will it end up like the internet where there's sort of free domain and people can do open source stuff and collaborate and I hope it's the former. Okay, so as a capitalist, ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
Josh Wolfe States Most Companies He Invests In Spin Out From Academic or Government Sectors
Josh Wolfe States Pleasure In Having Small Companies Get Funding From Lux Capital and Build Their Organizations
